Steve Miller - 20 Aug 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Op. & Scientific Officer
Signature
/s/ Steve Miller
Issuer symbol
CPRX
Transactions as of
20 Aug 2024
Net transactions value
-$3,052,900
Form type
4
Filing time
22 Aug 2024, 17:00:11 UTC
Previous filing
16 Feb 2024
Next filing
25 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale $1,013,050 -50,000 -6.1% $20.26 775,124 20 Aug 2024 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Sale $1,010,600 -50,000 -6.5% $20.21 725,124 20 Aug 2024 Direct F1, F3
transaction CPRX Common stock, par value $0.001 per share Sale $1,029,250 -50,000 -6.9% $20.58 675,124 20 Aug 2024 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Shares were sold in various lots from $20.12 to $20.525 per share. The price listed represents a weighted average price for the shares sold.
F3 Shares were sold in various lots from $20.12 to $20.49 per share. The price listed represents a weighted average price for the shares sold.
F4 Shares were sold in various lots from $20.325 to $20.71 per share. The price listed represents a weighted average price for the shares sold.